Search Results - "MÜLLER, R. P"

Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Study Group (GHSG) by Nogová, L., Reineke, T., Eich, H. T., Josting, A., Müller-Hermelink, H. K., Wingbermühle, K., Brillant, C., Gossmann, A., Oertel, J., Bollen, M. V., Müller, R.-P., Diehl, V., Engert, A.

“…Background: Since there are no randomized studies, the treatment of choice for patients with early stage lymphocyte-predominant Hodgkin's lymphoma (LPHL)…”
Get full text

Co‐morbidities and bleeding in elderly patients with haemophilia—A survey of the German, Austrian and Swiss Society of Thrombosis and Haemostasis Research (GTH) by Miesbach, W., Reitter‐Pfoertner, S.‐E., Klamroth, R., Langer, F., Wolf, H.‐H., Tiede, A., Siegmund, B., Scholz, U., Müller, P. R., Eichler, H., Pabinger, I.

“…Background Nowadays patients with haemophilia survive longer due to improvements in haemophilia care. It has been hypothesized that the bleeding type and…”
Get full text

Comparing long-term toxicity and efficacy of combined modality treatment including extended- or involved-field radiotherapy in early-stage Hodgkin's lymphoma by Sasse, S., Klimm, B., Görgen, H., Fuchs, M., Heyden-Honerkamp, A., Lohri, A., Koch, O., Wilhelm, M., Trenn, G., Finke, J., Müller, R.P., Diehl, V., Eich, H.T., Borchmann, P., Engert, A.

“…To evaluate long-term toxicity and efficacy of a combined modality strategy including extended-field radiotherapy (EF-RT) or involved-field radiotherapy…”
Get full text

Radiotherapy in elderly patients with inoperable esophageal cancer: Is there a benefit? by Semrau, R., Herzog, S.L., Vallböhmer, D., Kocher, M., Hölscher, A., Müller, R.-P.

“…Background Radiation oncologists increasingly face elderly cancer patients impaired by comorbidities and reduced performance status. As less data are available…”
Get full text

The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 “boost versus no boost” trial by Poortmans, P.M., Collette, L., Bartelink, H., Struikmans, H., Van den Bogaert, W.F., Fourquet, A., Jager, J.J., Hoogenraad, W., Müller, R.-P., Dubois, J.-B., Bolla, M., Van Der Hulst, M., Wárlám-Rodenhuis, C.C., Pierart, M., Horiot, J.-C.

“…To investigate the impact of the boost dose to the primary tumour bed in the framework of breast conserving therapy on local control, cosmetic results,…”
Get full text

Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group by Klimm, B., Eich, H.T., Haverkamp, H., Lohri, A., Koch, P., Boissevain, F., Trenn, G., Worst, P., Dühmke, E., Müller, R.P., Müller-Hermelink, K., Pfistner, B., Diehl, V., Engert, A.

“…Background: The optimal treatment of elderly patients with Hodgkin's lymphoma (HL) is still a matter of debate. Since many of these patients receive combined…”
Get full text

Prognostic factors in definitive radiochemotherapy of advanced inoperable esophageal cancer by Semrau, R., Herzog, S. L., Vallböhmer, D., Kocher, M., Hölscher, A. H., Müller, R.-P.

“…SUMMARY The aim of this study was to assess the efficacy and prognostic factors of definitive radiochemotherapy (RCT) for inoperable esophageal cancer. Between…”
Get full text

The German evidence-based guidelines for Hodgkin’s lymphoma: Aspects for radiation oncologists by Eich, H.T., Kriz, J., Schmidberger, H., Böll, B., Klimm, B., Rancea, M., Müller, R.-P., Engert, A.

“…This report reviews aspects of the German evidence-based guidelines for Hodgkin’s lymphoma relevant to radiation oncologists. Stage-adapted treatment is…”
Get full text

On isocentre adjustment and quality control in linear accelerator based radiosurgery with circular collimators and room lasers by Treuer, H, Hoevels, M, Luyken, K, Gierich, A, Kocher, M, Müller, R P, Sturm, V

“…We have developed a densitometric method for measuring the isocentric accuracy and the accuracy of marking the isocentre position for linear accelerator based…”
Get more information

Geometrical and dosimetrical characterization of the photon source using a micro-multileaf collimator for stereotactic radiosurgery by Treuer, H, Hoevels, M, Luyken, K, Hunsche, S, Kocher, M, Müller, R P, Sturm, V

“…A micro-multileaf collimator (microMLC) for stereotactic radiosurgery is used for determination of the spatial intensity distribution of the photon source of a…”
Get more information

Patienten in der Strahlentherapie by Karstens, J., Moll, M., Müller, R.-P., Bamberg, M.

Get full text

A phase III trial of topotecan and whole brain radiation therapy for patients with CNS-metastases due to lung cancer by Neuhaus, T, Ko, Y, Muller, R P, Grabenbauer, G G, Hedde, J P, Schueller, H, Kocher, M, Stier, S, Fietkau, R

“…Brain metastases represent an important cause of morbidity in patients with lung cancer and are associated with a mean survival of less than 6 months. Thus,…”
Get full text

Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: A prospective randomized study by Zieren, Hans U., Müller, Joachim M., Jacobi, Christoph A., Pichlmaier, Heinz, Müller, Rolf‐Peter, Staar, Sabine

“…s Postoperative radiation therapy following curative resection of squamous cell carcinoma of the esophagus was investigated in a prospective randomized study…”
Get full text

Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence by Muller, Dion R. P., Stenvers, Dirk J., Malekzadeh, Arjan, Holleman, Frederik, Painter, Rebecca C., Siegelaar, Sarah E.

“…Aims/hypothesis Glucagon-like peptide 1 (GLP-1) agonists and sodium-glucose co-transporter-2 (SGLT2) inhibitors are novel drugs which have recently seen rapid…”
Get full text

Vitamin E and neurological function by Muller, David P. R.

“…The clinical, neuropathological and electrophysiological evidence that vitamin E (α‐tocopherol) is essential for normal neurological function will be reviewed…”
Get full text

Involved-Node-Radiotherapie in frühen Stadien des Hodgkin-Lymphoms by Eich, H.T., Zimmermann, C., Müller, R.-P.

“…Zusammenfassung Die Strahlenbehandlung des Hodgkin-Lymphoms erfuhr eine Entwicklung von der Extended-Field- zur Involved-Field- (IF-)Radiotherapie bei…”
Get full text

Stereotactic LINAC radiosurgery for the treatment of brainstem cavernomas by Fuetsch, M., El Majdoub, F., Hoevels, M., Müller, R.P., Sturm, V., Maarouf, M.

“…Background The management of deep-seated cerebral cavernous malformations (CCMs) is still controversial. Although surgery remains the treatment of choice in…”
Get full text

Hybrid ab Initio Quantum Mechanics/Molecular Mechanics Calculations of Free Energy Surfaces for Enzymatic Reactions:  The Nucleophilic Attack in Subtilisin by Bentzien, J, Muller, R. P, Florián, J, Warshel, A

“…An effective approach for ab initio calculations of activation free energies of enzymatic reactions is developed and examined. This approach uses an empirical…”
Get full text

Lymphozytenprädominantes Hodgkin-Lymphom by Kriz, J., Müller, R.-P., Engert, A., Eich, H.T.

“…Zusammenfassung Das lymphozytenprädominante Hodgkin-Lymphom (LPHL) ist ein seltenes Lymphom der B-Zell-Reihe, das sich in seiner Pathologie sowie in seinen…”
Get full text

Radiation-induced hyposalivation and its treatment with oral pilocarpine by Niedermeier, W, Matthaeus, C, Meyer, C, Staar, S, Müller, R.-P, Schulze, H.-J

“…Objective. The aim of this study was to determine the effects of radiation on the secretion of saliva from mucous salivary glands in comparison with serous…”
Get full text